| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |